136 related articles for article (PubMed ID: 21557705)
1. Targeting miR-375 in gastric cancer.
Xu Y; Deng Y; Yan X; Zhou T
Expert Opin Ther Targets; 2011 Aug; 15(8):961-72. PubMed ID: 21557705
[TBL] [Abstract][Full Text] [Related]
2. MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2.
Ding L; Xu Y; Zhang W; Deng Y; Si M; Du Y; Yao H; Liu X; Ke Y; Si J; Zhou T
Cell Res; 2010 Jul; 20(7):784-93. PubMed ID: 20548334
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs as potential target gene in cancer gene therapy of gastrointestinal tumors.
Tazawa H; Kagawa S; Fujiwara T
Expert Opin Biol Ther; 2011 Feb; 11(2):145-55. PubMed ID: 21219233
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta.
Tsukamoto Y; Nakada C; Noguchi T; Tanigawa M; Nguyen LT; Uchida T; Hijiya N; Matsuura K; Fujioka T; Seto M; Moriyama M
Cancer Res; 2010 Mar; 70(6):2339-49. PubMed ID: 20215506
[TBL] [Abstract][Full Text] [Related]
5. microRNA expression profile in undifferentiated gastric cancer.
Katada T; Ishiguro H; Kuwabara Y; Kimura M; Mitui A; Mori Y; Ogawa R; Harata K; Fujii Y
Int J Oncol; 2009 Feb; 34(2):537-42. PubMed ID: 19148490
[TBL] [Abstract][Full Text] [Related]
6. The molecular mechanisms and therapeutic potential of microRNA-7 in cancer.
Gu DN; Huang Q; Tian L
Expert Opin Ther Targets; 2015 Mar; 19(3):415-26. PubMed ID: 25434362
[TBL] [Abstract][Full Text] [Related]
7. microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells.
Bandres E; Bitarte N; Arias F; Agorreta J; Fortes P; Agirre X; Zarate R; Diaz-Gonzalez JA; Ramirez N; Sola JJ; Jimenez P; Rodriguez J; Garcia-Foncillas J
Clin Cancer Res; 2009 Apr; 15(7):2281-90. PubMed ID: 19318487
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA dysregulation in gastric cancer: a new player enters the game.
Wu WK; Lee CW; Cho CH; Fan D; Wu K; Yu J; Sung JJ
Oncogene; 2010 Oct; 29(43):5761-71. PubMed ID: 20802530
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer.
Inoue T; Iinuma H; Ogawa E; Inaba T; Fukushima R
Oncol Rep; 2012 Jun; 27(6):1759-64. PubMed ID: 22407237
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs are implicated in the initiation and progression of gastric cancer.
Song J; Bai Z; Zhang Z
Chin Med J (Engl); 2014; 127(3):554-9. PubMed ID: 24451966
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-650 targets ING4 to promote gastric cancer tumorigenicity.
Zhang X; Zhu W; Zhang J; Huo S; Zhou L; Gu Z; Zhang M
Biochem Biophys Res Commun; 2010 Apr; 395(2):275-80. PubMed ID: 20381459
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-induced drug resistance in gastric cancer.
Dehghanzadeh R; Jadidi-Niaragh F; Gharibi T; Yousefi M
Biomed Pharmacother; 2015 Aug; 74():191-9. PubMed ID: 26349984
[TBL] [Abstract][Full Text] [Related]
13. Identification of new aberrantly expressed miRNAs in intestinal-type gastric cancer and its clinical significance.
Li X; Luo F; Li Q; Xu M; Feng D; Zhang G; Wu W
Oncol Rep; 2011 Dec; 26(6):1431-9. PubMed ID: 21874264
[TBL] [Abstract][Full Text] [Related]
14. Increased miR-146a in gastric cancer directly targets SMAD4 and is involved in modulating cell proliferation and apoptosis.
Xiao B; Zhu ED; Li N; Lu DS; Li W; Li BS; Zhao YL; Mao XH; Guo G; Yu PW; Zou QM
Oncol Rep; 2012 Feb; 27(2):559-66. PubMed ID: 22020746
[TBL] [Abstract][Full Text] [Related]
15. Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules.
Vo DD; Staedel C; Zehnacker L; Benhida R; Darfeuille F; Duca M
ACS Chem Biol; 2014 Mar; 9(3):711-21. PubMed ID: 24359019
[TBL] [Abstract][Full Text] [Related]
16. miR-21 microRNA expression in human gastric carcinomas and its clinical association.
Chan SH; Wu CW; Li AF; Chi CW; Lin WC
Anticancer Res; 2008; 28(2A):907-11. PubMed ID: 18507035
[TBL] [Abstract][Full Text] [Related]
17. The metastasis-associated microRNA miR-516a-3p is a novel therapeutic target for inhibiting peritoneal dissemination of human scirrhous gastric cancer.
Takei Y; Takigahira M; Mihara K; Tarumi Y; Yanagihara K
Cancer Res; 2011 Feb; 71(4):1442-53. PubMed ID: 21169410
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor.
Zhao X; Dou W; He L; Liang S; Tie J; Liu C; Li T; Lu Y; Mo P; Shi Y; Wu K; Nie Y; Fan D
Oncogene; 2013 Mar; 32(11):1363-72. PubMed ID: 22614005
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA expression and its implication for the diagnosis and therapeutic strategies of gastric cancer.
Wang J; Wang Q; Liu H; Hu B; Zhou W; Cheng Y
Cancer Lett; 2010 Nov; 297(2):137-43. PubMed ID: 20797817
[TBL] [Abstract][Full Text] [Related]
20. Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer.
Gao C; Zhang Z; Liu W; Xiao S; Gu W; Lu H
Cancer; 2010 Jan; 116(1):41-9. PubMed ID: 19890957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
